Compare ARK Genomic Revolution ETF (ARKG) vs Eaton Corporation plc (ETN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Eaton Corporation plc — how do they compare? ARK Genomic Revolution ETF trades at $40.64, while Eaton Corporation plc trades at $401.43 (market cap $158.15B). The key difference: Eaton Corporation plc pays a 1.08% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Eaton Corporation plc nearer its low. Which is the better fit depends on your goals.
| ARKG | ETN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $435.78 |
52-Week Low | $23.09 | $315.82 |
Market Cap | — | $158.15B |
Enterprise Value | — | $179.23B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Eaton (ETN) trades at $407.28, up 0.36% today, with a neutral technical stance and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $2.81 surpassing the $2.73 estimate. Fundamentals remain robust with a 36.89% gross margin and 20.87% ROE, though valuation multiples like the 39.85 P/E are elevated. Recent news highlights expansion in energy infrastructure and sustainability investments.
Outlook is positive given analyst consensus targets near $449.50 and zero sell ratings, but risks include high valuation sensitivity and projected 2026 cash flow pressure from increased investing activity. The stock offers growth exposure to power management and AI infrastructure trends, balanced by execution risks in a competitive industrial sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →
